cibisatamab
oportuzumab monatox
alacizumab
ublituximab
bezlotoxumab
intrabody
ozogamicin
Ab
immunosubunit
talizumab
bispecific
immunomodulant
ocrelizumab
chromobody
immunosphere
seroblock
durvalumab
biciromab
polyantibody
sulesomab
zolimomab
elsilimomab
heterophile
antiantibody
vobarilizumab
-mul-
antisubstance
agonistic monoclonal antibody
agglutinin
-ab
immunoproteasomal
tisotumab
antigenomic
affinity
antiplasma
elotuzumab
sonepcizumab
tucotuzumab
-a-
alloantibody
heterophile antibody
carlumab
Forssman antibody
bursopentine
bococizumab
heterophil antibody
tabalumab
immunocarrier
immunoantigen
immunobinding